Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 10, 2014 8:06 AM 2 min read

RealD Issued European Patent For XL Cinema System

by Eddie Staley Benzinga Editor
Follow
Global visual technology company RealD Inc. (NYSE:
RLD
) announced today the issuance to it by the European Patent Office of a patent that covers the fundamental optical architecture of the company's XL Cinema System, which is the world's brightest and most widely used cinema 3D projection technology. “The issuance of this European patent builds on the significant patent position we have globally around our XL Cinema System and validates our inventive approach,” said Robert Mayson, Managing Director of RealD Europe. “We place great value on our intellectual property and its ability to ensure the industry's brightest, premium visual experience for our partners and moviegoers around the world.” European Patent No. 2067066, entitled “Polarization conversion systems for stereoscopic projection,” is for a polarization conversion system (PCS) located in the output light path of a projector. The PCS may include a polarizing beam splitter, a polarization rotating element, a reflecting element, and a polarization switch, combining to direct multiple polarized light paths toward a projection screen to collectively form a brighter image for 3D content viewing in cinemas. “The European Patent Office is acknowledged as one of the most thorough patent offices worldwide and the grant of this patent following more than six years of examination indicates the uniqueness of RealD's technology,” added Mayson. Complementing the European Patent Office issuance, patents covering the optical design of the RealD XL Cinema System have been issued or are pending in many countries and territories, including the United States, China, Japan, S. Korea, Australia, Brazil, Canada, India, Mexico and Russia. RealD has more than 60 issued patents around the world covering aspects of its XL Cinema System technology and hundreds more patents issued or pending covering other innovative visual technologies. With intellectual property dating back to 2006, the RealD XL Cinema System was introduced in 2008 and today is the world's most widely used 3D cinema projection technology with more than 15,000 units installed around the world. The XL Cinema System delivers greater light efficiency than other 3D cinema projection technologies, and as a result, it provides a superior projected 3D image at a lower operating cost. The world's most widely used 3D cinema technology, RealD 3D is installed in approximately 26,000 auditoriums by approximately 1,000 exhibitors in 73 countries around the world (as of September 30, 2014).
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
NewsPress Releases
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...